In vitro fertilization and risk of breast and gynecologic cancers: a retrospective cohort study within the Israeli Maccabi Healthcare Services.

[1]  C. Holman,et al.  In vitro fertilization, endometriosis, nulliparity and ovarian cancer risk. , 2013, Gynecologic oncology.

[2]  C. Holman,et al.  In vitro fertilization and breast cancer: is there cause for concern? , 2012, Fertility and sterility.

[3]  M. Stein,et al.  Uptake of Pap smears among women in a large Israeli HMO between 2006 and 2008. , 2012, Public health.

[4]  J. Weissfeld,et al.  Use of Fertility Drugs and Risk of Ovarian Cancer: Results from a U.S.-Based Case–Control Study , 2012, Cancer Epidemiology, Biomarkers & Prevention.

[5]  L. Brinton,et al.  Fertility Drugs and the Risk of Breast and Gynecologic Cancers , 2012, Seminars in Reproductive Medicine.

[6]  M. Pike,et al.  Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case–control studies , 2012, The Lancet. Oncology.

[7]  B. Lunenfeld,et al.  Are infertility treatments a potential risk factor for cancer development? Perspective of 30 years of follow-up. , 2012, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[8]  L. Shulman.  Cancer morbidity in a cohort of 9175 Finnish women treated for infertility , 2012 .

[9]  F. V. van Leeuwen,et al.  Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large Dutch cohort , 2011, Human reproduction.

[10]  G. Chodick,et al.  Further evidence on the high prevalence of male factor infertility diagnosis in Israel. , 2011, The Israel Medical Association journal : IMAJ.

[11]  B. Källén,et al.  Malignancies among women who gave birth after in vitro fertilization. , 2011, Human reproduction.

[12]  S. Franceschi,et al.  Estrogen and ERα: Culprits in cervical cancer? , 2010, Trends in Endocrinology & Metabolism.

[13]  S. Kjaer,et al.  Use of fertility drugs and risk of uterine cancer: results from a large Danish population-based cohort study. , 2009, American journal of epidemiology.

[14]  P. Merviel,et al.  [Ovarian stimulation and follicular puncture risks]. , 2009, Gynecologie, obstetrique & fertilite.

[15]  V. McCormack,et al.  Ovulation-stimulation drugs and cancer risks: a long-term follow-up of a British cohort , 2009, British Journal of Cancer.

[16]  P. Dickman,et al.  Ovarian epithelial neoplasia after hormonal infertility treatment: long-term follow-up of a historical cohort in Sweden. , 2009, Fertility and sterility.

[17]  Y. Friedlander,et al.  Cancer risk after exposure to treatments for ovulation induction. , 2008, American journal of epidemiology.

[18]  J. Thigpen.  Use of fertility drugs and risk of ovarian cancer: Danish population based cohort study , 2009 .

[19]  L. Shulman.  Breast cancer incidence after hormonal infertility treatment in Sweden: a cohort study , 2009 .

[20]  H. Copin,et al.  Quatorzièmes Journées nationales de la FFER ( Clermont-Ferrand , 18 – 20 novembre 2009 ) Risques de la stimulation ovarienne et du prélèvement ovocytaire Ovarian stimulation and follicular puncture risks , 2009 .

[21]  T. Peretz,et al.  Beginning IVF Treatments After Age 30 Increases the Risk of Breast Cancer: Results of a Case–Control Study , 2008, The breast journal.

[22]  Gretchen L. Gierach,et al.  Menopausal Hormone Therapy and Breast Cancer Risk in the NIH-AARP Diet and Health Study Cohort , 2008, Cancer Epidemiology Biomarkers & Prevention.

[23]  J. Olsen,et al.  Risk of breast cancer and gynecologic cancers in a large population of nearly 50,000 infertile Danish women. , 2008, American journal of epidemiology.

[24]  A. Halevy,et al.  The Possible Association between IVF and Breast Cancer Incidence , 2008, Annals of Surgical Oncology.

[25]  J. Olsen,et al.  Relationships of uterine and ovarian tumors to pre-existing chronic conditions. , 2007, Gynecologic oncology.

[26]  K. Frederiksen,et al.  Risk of Breast Cancer After Exposure to Fertility Drugs: Results from a Large Danish Cohort Study , 2007, Cancer Epidemiology Biomarkers & Prevention.

[27]  P. Kristiansson,et al.  Tumour incidence in Swedish women who gave birth following IVF treatment. , 2007, Human reproduction.

[28]  W. Willett,et al.  A prospective study of infertility due to ovulatory disorders, ovulation induction, and incidence of breast cancer. , 2006, Archives of internal medicine.

[29]  J. Schenker,et al.  Infertility, Ovulation Induction Treatments and the Incidence of Breast Cancer—a Historical Prospective Cohort of Israeli Women , 2006, Breast Cancer Research and Treatment.

[30]  R. Barnes.  Breast Cancer Risk Associated With Being Treated for Infertility: Results From the French E3N Cohort Study , 2006 .

[31]  J. Lubin,et al.  Uterine cancer after use of clomiphene citrate to induce ovulation. , 2005, American journal of epidemiology.

[32]  L. Brinton,et al.  Breast cancer risk associated with ovulation-stimulating drugs. , 2004, Human reproduction.

[33]  L. Brinton,et al.  Ovarian Cancer Risk After the Use of Ovulation-Stimulating Drugs , 2004 .

[34]  D. Polyzos,et al.  Effects of tamoxifen on the human female genital tract: review of the literature. , 2003, European journal of gynaecological oncology.

[35]  V. Beral,et al.  Cancer incidence following treatment for infertility at a clinic in the UK. , 2002, Human reproduction.

[36]  M. Goodman,et al.  Infertility, fertility drugs, and ovarian cancer: a pooled analysis of case-control studies. , 2002, American journal of epidemiology.

[37]  L. Devoto,et al.  Clomiphene citrate and ovulation induction. , 2002, Reproductive biomedicine online.

[38]  C. la Vecchia,et al.  Use of fertility drugs and risk of ovarian cancer. , 2001, Human reproduction.

[39]  J. Daling,et al.  Complexity of surveillance for cancer risk associated with in-vitro fertilisation , 1999, The Lancet.

[40]  A. Venn,et al.  Risk of cancer after use of fertility drugs with in-vitro fertilisation , 1999, The Lancet.

[41]  H. Risch.  Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. , 1999, Journal of the National Cancer Institute.

[42]  C. la Vecchia,et al.  Treatment for fertility and risk of ovarian tumors of borderline malignancy. , 1998, Gynecologic oncology.

[43]  S. Kjaer,et al.  Infertility, fertility drugs, and invasive ovarian cancer: a case-control study. , 1997, Fertility and sterility.

[44]  L. Brinton,et al.  Citations from the literature , 2003 .

[45]  J. Schenker,et al.  Human menopausal gonadotropin and the risk of epithelial ovarian cancer. , 1996, Fertility and sterility.

[46]  S. Self,et al.  In situ and invasive cervical carcinoma in a cohort of infertile women. , 1996, Fertility and sterility.

[47]  E. Adashi,et al.  Adverse Effects of Fertility Drugs , 1994, Drug safety.

[48]  S. Self,et al.  Ovarian tumors in a cohort of infertile women. , 1994, The New England journal of medicine.

[49]  J Halpern,et al.  Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. I. Methods. Collaborative Ovarian Cancer Group. , 1992, American journal of epidemiology.

[50]  A S Whittemore,et al.  Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. III. Epithelial tumors of low malignant potential in white women. Collaborative Ovarian Cancer Group. , 1992, American journal of epidemiology.

[51]  A. Whittemore,et al.  Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group. , 1992, American journal of epidemiology.

[52]  A. Glasier.  5 Clomiphene citrate , 1990 .

[53]  A. Glasier.  Clomiphene citrate. , 1990, Bailliere's clinical obstetrics and gynaecology.

[54]  S. Fishel,et al.  Follicular stimulation for high tech pregnancies: are we playing it safe? , 1989, BMJ.

[55]  David R. Cox,et al.  Regression models and life tables (with discussion , 1972 .